Feline Toxoplasmosis and its Zoonotic Implications
Kari Addante, DVM; Holly A. Moore, DVM; Bruce E. LeRoy, DVM, PhD
Class of 2006 (Addante) and Department of Pathology (Moore, LeRoy), College of
Veterinary Medicine, University of Georgia, Athens, GA 30602-7388

Introduction
The coccidian Toxoplasma gondii is an obligate intracellular parasite
that can infect virtually all warm-blooded animals including humans. Members of the
species Felidae, however, are the only known definitive hosts for the sexual stages
of T. gondii and, thus, serve as the primary reservoir for the pareasite. Numerous
other species are paratenic hosts and serve as intermediate hosts required for completion
of the parasites life cycle but in which developmental changes do not occur.
In the United States, the percentage of domestic cats seropositive for T. gondii is
estimated to be between 16 - 43% based on regional variances.1,2 The high
serological prevalence of toxoplasmosis and its zoonotic potential underscore the
importance of veterinarians full understanding of both the disease course and the
role of domestic cats in the T. gondii life cycle.3
Epidemiology
T. gondii sporulated oocysts, bradyzoites, and tachyzoites may all cause
infection.2 Cats, as obligate carnivores, primarily contract toxoplasmosis
through ingestion of infected host tissue cysts. As definitive hosts, cats alone can
complete the enteroepithelial life cycle. Extraintestinal cycling of T. gondii occurs in cats, as well, along with all other susceptible species that serve as
intermediate hosts. In cats, the enteroepithelial and extraintestinal developmental cycles
may occur simultaneously.4
Enteroepithelial Life Cycle
Upon ingestion of tissue from infected hosts, proteolytic digestive enzymes degrade the
tissue cysts and release the bradyzoites.2 These slowly dividing forms of the
coccidian are capable of a sexual reproductive process called merogany that occurs only in
cats.5 Through merogany, bradyzoites undergo repeated nuclear/cytoplasmic
fission to yield microgamonts (male-like) and macrogamonts
(female-like).5 Microgamonts further divide to form microgametes
which are then able to fertilize the macrogamont.5 A protective wall
encapsulates fertilized macrogamonts to form the zygote-containing oocyst. Unsporulated
oocysts are non-infective and are shed into the environment from the feces in most naïve
cats, 10 days or less after tissue cyst ingestion.2,6 Oocyst sporulation to the
infective form occurs approximately 1-5 days later, after exposure to ambient air and
humidity.2 This is the period of most concern for exposure to pregnant women
who may be cleaning the cat litter box. Each sporulated oocyst contains eight sporozoites
that can survive in the environment for up to 18 months7, and insects
such as roaches and earthworms may function as transport hosts by dispersing oocysts from
their initial shedding point .7
There are several reasons why cats who ingest oocysts or tachyzoites develop T.
gondii infections less frequently (approximately 20%) and exhibit a prolonged
prepatent period when compared to those cats ingesting tissue cysts.6 Bradyzoites are able to serve as direct precursors to enteroepithelial cycling (and thus a
shorter prepatent period) whereas oocysts or tachyzoites must first develop to the
bradyzoite stage.2, 5 Moreover, the decreased infection rate may be related to
the fact that each tissue cyst contains a large number of bradyzoites whereas only eight
sporozoites are within an oocyst.2 Finally, tachyzoite ingestion is less likely
to result in patency as they are often destroyed by gastrointestinal digestive enzymes.2
Extraintestinal Life Cycle
Ingested sporulated oocysts release sporozoites into the gastrointestinal
tract of the host.6 Sporozoites enter cells of the intestine and lymph nodes
where they undergo endodyogeny to form rapidly dividing tachyzoites that disemminate
throughout the body through the blood and lymphatic vasculature.6 The
tachyzoite tissue phase that develops within a host or is ingested may result in
bradyzoite tissue cyst formation within the brain, skeletal muscle, and liver (see Figures
1,2). These tissue cysts may persist for the life of the host,7 and the potential for recrudescence exists as tissue cysts rupture and release
bradyzoites.2 Both ingested bradyzoites and those released through host cyst
rupture are capable of asexual development to tachyzoites, thereby perpetuating the cycle.5
 |
 |
| Figure 1. Raccoon brain. Multiple Toxoplasma gondii tissue cysts (arrow) within
white matter. H&E stain, 40X. |
Figure 2. Dog muscle. Myonecrosis and myositis with intralesional T. gondii tissue cysts (arrows) containing developing bradyzoites. H&E stain, 40X. |
Vertical and Iatrogenic Infections
Transplacental and transmammary transmission occurs in carnivores, omnivores,
and herbivores as a result of naïve host infection during pregnancy.2,8 In
congenital transmission, T. gondii replicates and infects placental tissue whereby
it gains access to the fetus. Outcome in these cases is most severe (e.g. abortion,
stillbirth) when infection occurs during the first half of the pregnancy.2 Alternatively, when tachyzoites are shed in milk, transmammary transmission may occur and
result in clinical illness of varying degrees in newborns.2 Additionally,
although less commonly observed, infection is also possible in recipients of donor fluids
or tissue thereby underscoring the importance of thoroughly screening donors as T.
gondii can survive at 4°C for up to 50 days in stored blood products.9
Clinical Disease
Although there is a high seroprevalence of T. gondii infection among Felidae,
significant clinical disease in domestic cats is relatively infrequent. When disease does
occur, it may be attributed to a primary infection in which an inadequate immune response
failed to arrest invasive tachyzoites.1,2,4 Alternatively, disease may result
from reactivation of subclinical infection in an immunocompromised individual with
encysted bradyzoites which may then form rapidly multiplying tachyzoites.2 Such
incidents are thought to relate directly to variables such as the age and sex of the host,
presence of immunodeficient states (such as feline leukemia virus or feline
immunodeficiency virus infection), concomitant stress or illness, and
organism load.2
Clinical illness appears to be most frequent among cats less than 2 years of age which
may be due in part to an insufficient immune response by young cats.1,2,4 In
one study involving 25 kittens experimentally infected with neonatal T. gondii infection, 3 kittens were stillborn.10 Among the 22 live kittens, approximately
95% exhibited proliferative interstitial pneumonia, necrotizing hepatitis, myocarditis,
and skeletal myositis to the extent that euthanasia was necessary.10 Infected
neonates also often develop central nervous system infections.2
Organism ingestion followed by initial enteroepithelial replication may lead
to a self-limiting small bowel diarrhea that occurs due to an IgA response elicited by T.
gondii resulting in increased intestinal secretions.2 Clinical illness may
progress when naïve hosts are infected or when prior infections are reactivated.
Extraintestinal spread of the parasite may occur as rapid multiplication of tachyzoites
within host cells results in cell rupture, promoting organism dissemination and,
ultimately, tissue necrosis.1,2,4 Disease onset may be sudden or insidious, and
clinical signs are often multiple and varied as most types host cells are vulnerable to
infection.11 Respiratory, CNS, hepatic, pancreatic, cardiac, and ocular tissues
were among the most commonly affected tissues in a group of 100 adult cats with confirmed
toxoplasmosis.7 Associated clinical signs included dyspnea, tachypnea,
intermittent fever, icterus, vomiting, weight loss, hyperesthesia, shifting lame lameness,
ataxia, dermatitis, and death.2
Clinicopathologic Findings
Laboratory testing may detect several abnormal parameters in animals with
acute systemic toxoplasmosis. A nonregenerative anemia may be detected with a concurrent
neutrophilic leukocytosis, lymphocytosis, monocytosis, and eosinophilia.2 The
biochemical profile of cats with chronic toxoplasmosis may demonstrate hyperglobulinemia
due to chronic antigenic stimulation and immune response. Hepatocellular disease may
result in elevated alanine aminotransferase (ALT) enzyme activity, and muscle damage may
cause an increase in aspartate aminotransferase (AST) and creatine kinase (CK) activity.2 Hyperbilirubinemia may occur in cats with cholangiohepatitis or hepatic lipidosis
secondary to liver dysfunction.2
Histologically, lesions associated with toxoplasmosis are a result of cell death
secondary to intracellular replication of T. gondii. The associated inflammatory
reaction is primarily composed of macrophages in adult cats and neutrophils and
macrophages (pyogranulomatous), with or without a lymphoplasmacytic component, in
neonates.10,11 Tissue cysts often persist in the absence of host reaction.
In the CNS, encephalitis may result from tachyzoites primarily infecting astrocytes.11 A resultant diffuse necrotizing and nonsuppurative lymphocytic infiltrate may develop in
the brain and extend to the meninges.11 Necrotizing hepatitis with focal areas
of coagulative lobular necrosis may be observed with the presence of few organisms.11 Other gross lesions include pulmonary edema and congestion with failure of lung collapse
as well as multifocal areas of firm white, yellow, or gray discoloration in the pulmonary
parenchyma.11 Toxoplasma organisms invade type 1 and 2 pneumocytes as
well as pulmonary alveolar macrophages, fibroblasts, endothelial cells, and smooth muscle
cells.11 The subsequent proliferative reaction in alveolar walls may resemble
adenomatosis. Severe lymphadenopathy may occur.11 Pericardial effusion is
occasionally reported and likely due to organisms invading the myocardium.2 Intestinal lymphatic tissue invasion may result in small bowel ulcerative disease.11 If the muscularis is involved, occasionally a chronic necrotizing process leads to large
granulomatous nodules that can impede the transport of luminal contents and possible
lymphangiectasia.2,11 Ocular lesions are frequent and may cause inflammation of
the retina or anterior segment (anterior uveitis) with granulomatous inflammation being
the prominent cytologic feature.2 Placental lesions can include focal necrosis
with or without foci of mineralization.7
Diagnosis
Diagnosis of clinical toxoplasmosis in cats is challenging due to the high
seroprevalence of the infection among non-affected cats as well as the many potential
antibody responses that may occur in disease as well as in health. Since seroconversion
also occurs in the absence of clinical disease, titers should be interpreted in conjuction
with clinical signs consistent with toxoplasmosis. Accordingly, the exclusion of other
causes of clinical disease paired with serologic evidence (such as a four-fold increase in
titer) and a positive response to appropriate therapy may be simultaneously employed in
order to reach a tentative diagnosis.2
Serology
Near 80% of cats are thought to develop IgM antibodies within 1-2 weeks after
exposure. These antibodies may remain detectable for months to years.2 As a
result, the presence of IgM antibody cannot reliably be used to predict recent infection
and oocyst shedding. Similarly, IgG antibodies may not develop for 4-6 weeks and may peak
in 2-3 weeks with some cats remaining high for several years.1,2,4
T. gondii titers may be by indirect fluorescent antibody testing, modified
agglutination, enzyme-linked immunosorbent antibody assays, and Sabin-Feldman serologic
testing.7 Because many cats have T. gondii antibodies from previous
exposure, it is necessary to demonstrate either a four-fold rise in IgG titers over a 2-3
week period or a single high IgM titer (> 1:64).1,2,4,7 Clinical signs may
develop before seroconversion occurs in 1-2 weeks or not until after peak titers have
developed.1,2,7 For these reasons, antibody titers may be difficult to
interpret and single antibody titers are often insufficient for definitive diagnosis.2
Cytology
Definitive diagnosis for T. gondii is possible through identification
of the organisms in body tissue or fluids (see Figures 3,4). In acute illness, tachyzoites may be present in large numbers in body fluids
such as abdominal and pleural effusions.2 Peripheral blood smears,
cerebrospinal fluid (CSF), fine needle aspirates of tissues, and airway washings are less
likely to provide direct organism detection.2 Such biologic samples can be used
for bioassays in mice, tissue cultures, or PCR to demonstrate the presence of T. gondii organisms.2,7
 |
 |
| Figure 3. Transtracheal washing from a cat. A large binucleate phagocytic cell
contains intracytoplasmic Toxoplasma tachyzoites (arrow). Wrights stain, 50X. |
Figure 4. Fine needle aspirate from cat lung. A ruptured large mononuclear cell
with multiple Toxoplasma tachyzoites. Wrights stain, 100X. |
Fecal samples may also be examined for the presence of T. gondii oocysts but are
relatively insensitive and nonspecific. Clinical signs usually do not develop until after
oocyst shedding has ceased, and oocyst shedding may occur in the absence of clinical
toxoplasmosis.1,2,7 Furthermore, the microscopic appearance of T. gondii oocysts is indistinguishable from the oocysts of other coccidians such as Hammondia and Besnoitia that may also infect cats.2,7
CNS and Aqueous Humor Analysis
Diagnosis of toxoplasmosis-induced uveitis or encephalitis is also possible through
antibody testing and subsequent calculation of Goldman-Witmer coefficients.2, 7 Antibody
measurements for T. gondii and another agent-specific-antibody (ASA) in aqueous
humor or CSF must be compared to the same measurements obtained for serum.2,7 The ASA should be from an agent that is expected to have a high serum titer but does not
cause CNS disease. Calicivirus antibody has been used for this purpose in cats.2 This procedure allows for higher antibody levels occurring simply due to increased
vascular permeability that may result from inflammation of any cause.2 To
calculate the coefficient, the ratio of the T. gondii antibody level in the aqueous
or CSF over the T. gondii antibody level in the serum is multiplied by the ratio of
the ASA level in body fluids (i.e. in the aqueous or CSF) over the serum ASA level.2,7 A coefficient greater than 1 is significant, and a result greater than 8 is considered
compatible with T. gondii infection.2,7
Treatment
| Note:
Treatment of animals should only be performed by a licensed veterinarian.
Veterinarians should consult the current literature and current pharmacological
formularies before initiating any treatment protocol. |
Clindamycin at 10-12mg/kg every 8-12 hours for 4 weeks, by oral or parenteral
route, is often used for treatment of cats with clinical toxoplasmosis.2,7 Resolution of clinical signs may begin within 24 to 48 hours of instituting therapy.2 Clindamycin doses necessary to treat toxoplasmosis in cats may lead to such adverse
reactions as anorexia, vomiting, and diarrhea.12 If clindamycin cannot be
tolerated at the recommended dose, pyrimethamine or trimethoprim may be combined with a
sulfonamide for treatment. However, the risk of anti-folate drug related bone marrow
suppression necessitates frequent monitoring for hematologic abnormalities.2,7 Dietary supplementation with folic acid (5mg/day) or yeast (100 mg/kg) may aide in
correcting hematopoietic disruption.2,7 The prognosis for cats with
toxoplasmosis is guarded, as available drugs are unable to completely eliminate the
parasite and the risk for relapse of clinical disease is possible.2 Recurrence
is particularly common in immunocompromised cats.2,7
Zoonotic Potential
An estimated 30-50% of the human population is currently infected with Toxoplasma in the asymptomatic cyst form.3 In immunocompromised patients, the cyst form
may potentially lead to serious disease.3,13 Because of the potential for
disastrous outcomes in infections that occur during pregnancy, women planning to become
pregnant may opt for T. gondii antibody testing.13 Positive antibody
detection indicates previous infection and suggests that the likelihood of congenital
transmission upon re-exposure to the parasite during pregnancy is limited.13 Conversely, antibody-negative women are at far greater risk of transmitting Toxoplasma to the fetus if they should become infected during pregnancy.13 This risk
becomes magnified as 70 million domestic cats are kept as pets in American households,
making them the most numerous in the nation among domestic companion species.14 Clearly, it is vital to clarify the role of cats in the transmission of Toxoplasma to humans.
The primary means by which most humans are infected with T. gondii are through
oocyst-contaminated soil and eating undercooked infected meat such as lamb and pork.3 People who own cats are not at a significantly higher risk for T. gondii infection
than those who do not.7 Since oocysts are highly resistant to environmental
conditions, exposure can be minimized by wearing rubber gloves during contact and washing
hands thoroughly after possible exposure to potentially contaminated soil.1,3,13 Areas such as sandboxes should be kept covered to avoid oocyst contamination. 1,3,13 Meat should routinely be cooked to an internal temperature of 70°C (158°F) for at least
15 to 30 minutes in order to destroy tissue cysts.13
Restricting the access of pet cats to hunting and disallowing the ingestion of uncooked
meat may prevent cats exposure to T. gondii. When they are exposed. most healthy
cats will shed oocysts only during acute infection.1,2,7,13 As the infected cat
develops an immune response, oocyst shedding is halted, and the development of tachyzoites
is arrested with the resultant formation of bradyzoites (slowly replicating forms of the
organism) conyained within tissue cysts.2 Cats previously unexposed to T.
gondii usually begin shedding oocysts between 3 and 10 days after ingestion of
infected tissue and continue shedding for 10-14 days, during which time many millions of
oocysts may be produced.1,2,7,13 However, once a cat has developed an immune
response, further shedding of oocysts is extremely rare.1,2,7,13 In the few
cats that do re-excrete oocysts after another exposure to Toxoplasma, the number of
oocysts shed is lower and may even be insufficient to transmit the parasite effectively.2,7 An antibody-negative cat, particularly a kitten, is most susceptible to infection and will
shed oocysts for one to two weeks post-exposure to T. gondii.2 In a
healthy cat, positive antibody titers are suggestive that the cat is immune, not excreting
oocysts, and an unlikely source of infection.2 In any case, daily cleaning of
feces from litter boxes, paired with regular disinfection of the boxes, will prevent any
oocysts that are shed from sporulating to the infective form.1,2,7,13 It is
still recommended, however, that women who are or may become pregnant avoid cleaning the
litter box.
References
1. Lappin MR. General Concepts in Zoonotic Disease Control. Vet Clin North Am Small
Anim Pract 2005;35:1-20.
2. Dubey JP, Lappin MR. Toxoplasmosis and Neosporosis. In: Greene C, ed. Infectious
Diseases of the Dog and Cat, 3rd ed. St. Louis, MO: Elsevier, 2006. pp 754-768.
3. Toxoplasmosis. United States Center for Disease Control, 22 Nov. 2004.
<http://www.dpd.cdc.gov/dpdx/HTML/Toxoplasmosis.htm>
4. Lindsay DS, Blagburn, BL. Coccidial Parasites of Dogs and Cats. Compend Contin Educ
Pract Vet 1991;13:759-765.
5. Bowman, DD. Georgis Parasitology for Veterinarians. St. Louis, MO: Saunders,
2003. pp 100-102.
6. Dubey, JP, Speer CA, et al. Oocyst-induced murine toxoplasmosis: life cycle,
pathogenicity, and stage conversion in mice fed Toxoplasma gondii oocysts. J
Parasitol 1997;83:870-872.
7. Lindsay, DS, Blagburn, BL: Feline toxoplasmosis and the importance of the Toxoplasma
gondii oocyst. Compend Contin Educ Pract Vet 1997;19:448-461.
8. Bonametti AM, Passos JN, Da Silva EMK, and Macedo ZS. Probable transmission of acute
toxoplasmosis through breast feeding. J Trop Ped 1997;43:116.
9. Freij BJ, Sever JL. Toxoplasmosis. Paed in Rev 1991;12:227-36.
10. Dubey JP, Mattix ME, Lipscomb TP. Lesions of neonatally induced toxoplasmosis in
cats. Vet Pathol 1996;33:290-295.
11. Jones TC, Hunt RD, King NW. Veterinary Pathology. Baltimore, MD: Lippincott, 1996.
pp 555-561.
12. Plumb DC: Veterinary Drug Handbook. Ames, IA: Iowa State Press, 2002. pp 206-209.
13. Montoya JG, Rosso F: Diagnosis and Management of Toxoplasmosis. Clin Perinatol
2005;32:705-726.
14. Veterinary Market Statistics. AVMA. 2002.
<http://www.avma.org/membshp/marketstats/comp_exotic.asp>
Acknowledgement
"Cat Nap" watercolor by Sinclair Stratton (c) 2002 is from the Gallery section of his website and is used with permission. |